how safe is ghk cu Peptide Injection and GHK GHK-CU – Research Peptide |

Tesamorelin is typically administered via subcutaneous injection at 2 mg once daily, usually in the abdomen, for visceral fat reduction

- [Retatrutide Phase 2 Trial Supplementary Appendix: Drug Preparation]( *New England Journal of Medicine*, 2023

In the literature, both peptides appear in the context of models involving soft tissues, endothelial function, actin organisation and cellular processes involved in repair and remodelling of biological structures

Contact us at (786) 502-2260 if you want to review the primary literature before your consultation

Yasui T, Fukui K, Nara T, Habata I, Meyer W, Tsukise A: Immunocytochemical localization of lysozyme and -defensin in the apocrine glands of the equine scrotum